Aster DM Healthcare (NSE:ASTERDM, BOM:540975) has received approval from the Competition Commission of India for its proposed merger with Quality Care India, according to a Wednesday filing to the Indian stock exchanges.
The transaction also includes Quality Care India's private equity investors and shareholders- BCP Asia II TopCo IV and Centella Mauritius Holdings.
Before the merger, Aster will purchase a 5% stake in Quality Care India from BCP Asia and Mauritius Holdings. This transaction will be in consideration of a primary share issuance by Aster, the competition watchdog said in a separate statement.
On completion of the merger, investors including BCP Asia, Mauritius Holdings and some minority stakeholders, will hold a certain stake in the merged entity. However, Mauritius Holdings will have a less than 10% stake without control rights in Aster DM Quality Care.
The company's shares were up 2% in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.